Key facts
- Notable investors include China Growth Capital, CDBI Partners, Hengqin Financial Investment, Hygeia Capital, Rays Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Sirius Medtech
- ·The full record, as it builds
Funding rounds
No funding rounds for Sirius Medtech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sirius Medtech
Developer of interventional medical devices intended to treat heart failure and lung diseases. The company develops interventional medical devices to treat heart failure and Pulmonary Embolism (PE), enabling patients to improve recovery process of cardiovascular diseases.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2019
- Website
- qichenmedical.com/
- Ownership
- Privately Held (backing)
Sirius Medtech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sirius Medtech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sirius Medtech in its N-PORT filings yet. We sweep new filings monthly.